 |
인쇄하기
취소
|
238 digestives and circulation drugs likely to be delisted in health insurance
The Health Insurance Review and Assessment Service announced on May 28 an interim report of economic effectiveness over drugs belonging to five therapeutic categories.
According to the report, a total of 238 medicines acting on blood circulation and digestive system will be delisted from national health insurance benefits due to lack of cost saving effects.
The controversial active ingred...
According to the report, a total of 238 medicines acting on blood circulation and digestive system will be delisted from national health insurance benefits due to lack of cost saving effects.
The controversial active ingred...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.